Načítá se...
Belimumab in systemic lupus erythematosus: a perspective review
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B-lymphocyte stimulator (also known as B cell activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration and the European Medicines Evaluation Agency for treatment of au...
Uloženo v:
| Vydáno v: | Ther Adv Musculoskelet Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530384/ https://ncbi.nlm.nih.gov/pubmed/26288663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15588514 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|